Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Eurolife Brands

CNSX:EURO
Snowflake Description

Adequate balance sheet and overvalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
EURO
CNSX
CA$13M
Market Cap
  1. Home
  2. CA
  3. Healthcare
Company description

Eurolife Brands Inc. operates as a business technology company within the health sciences sector in the United States and internationally. The last earnings update was 81 days ago. More info.


Add to Portfolio Compare Print
  • Eurolife Brands has significant price volatility in the past 3 months.
EURO Share Price and Events
7 Day Returns
0%
CNSX:EURO
-0.5%
CA Healthcare Services
0.6%
CA Market
1 Year Returns
-49.1%
CNSX:EURO
19.8%
CA Healthcare Services
5.8%
CA Market
EURO Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Eurolife Brands (EURO) 0% 0% -30% -49.1% - -
CA Healthcare Services -0.5% 5.9% 31.8% 19.8% 9.9% 54.6%
CA Market 0.6% 0.5% 3.6% 5.8% 5% 14%
1 Year Return vs Industry and Market
  • EURO underperformed the Healthcare Services industry which returned 19.8% over the past year.
  • EURO underperformed the Market in Canada which returned 5.8% over the past year.
Price Volatility
Industry
5yr Volatility vs Market

EURO Value

 Is Eurolife Brands undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Eurolife Brands. This is due to cash flow or dividend data being unavailable. The share price is CA$0.035.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Eurolife Brands's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Eurolife Brands's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
CNSX:EURO PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-09-30) in CAD CA$-0.03
CNSX:EURO Share Price ** CNSX (2020-02-14) in CAD CA$0.04
North America Healthcare Services Industry PE Ratio Median Figure of 11 Publicly-Listed Healthcare Services Companies 59.27x
Canada Market PE Ratio Median Figure of 511 Publicly-Listed Companies 15.94x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Eurolife Brands.

CNSX:EURO PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:EURO Share Price ÷ EPS (both in CAD)

= 0.04 ÷ -0.03

-1.02x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Eurolife Brands is loss making, we can't compare its value to the North America Healthcare Services industry average.
  • Eurolife Brands is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does Eurolife Brands's expected growth come at a high price?
Raw Data
CNSX:EURO PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -1.02x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
North America Healthcare Services Industry PEG Ratio Median Figure of 10 Publicly-Listed Healthcare Services Companies 3.49x
Canada Market PEG Ratio Median Figure of 248 Publicly-Listed Companies 1.13x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Eurolife Brands, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Eurolife Brands's assets?
Raw Data
CNSX:EURO PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-09-30) in CAD CA$0.02
CNSX:EURO Share Price * CNSX (2020-02-14) in CAD CA$0.04
Canada Healthcare Services Industry PB Ratio Median Figure of 12 Publicly-Listed Healthcare Services Companies 2.28x
Canada Market PB Ratio Median Figure of 2,341 Publicly-Listed Companies 1.38x
CNSX:EURO PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:EURO Share Price ÷ Book Value per Share (both in CAD)

= 0.04 ÷ 0.02

2.22x

* Primary Listing of Eurolife Brands.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Eurolife Brands is good value based on assets compared to the CA Healthcare Services industry average.
X
Value checks
We assess Eurolife Brands's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare Services industry average (and greater than 0)? (1 check)
  5. Eurolife Brands has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

EURO Future Performance

 How is Eurolife Brands expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Eurolife Brands has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
26.3%
Expected Healthcare Services industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Eurolife Brands expected to grow at an attractive rate?
  • Unable to compare Eurolife Brands's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Eurolife Brands's earnings growth to the Canada market average as no estimate data is available.
  • Unable to compare Eurolife Brands's revenue growth to the Canada market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
CNSX:EURO Future Growth Rates Data Sources
Data Point Source Value (per year)
North America Healthcare Services Industry Earnings Growth Rate Market Cap Weighted Average 26.3%
North America Healthcare Services Industry Revenue Growth Rate Market Cap Weighted Average 14.4%
Canada Market Earnings Growth Rate Market Cap Weighted Average 10.4%
Canada Market Revenue Growth Rate Market Cap Weighted Average 5%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
CNSX:EURO Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
CNSX:EURO Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2019-09-30 0 -1 -7
2019-06-30 0 -2 -6
2019-03-31 0 -4 -6
2018-12-31 0 -2 -5
2018-09-30 0 -4 -4
2018-06-30 0 -2 -2
2018-03-31 -1 -1
2017-12-31 0 -1
2017-09-30 0 0 0
2017-06-30 0 0 0
2017-03-31 0 0 0
2016-12-31 0 0 0

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Eurolife Brands is high growth as no earnings estimate data is available.
  • Unable to determine if Eurolife Brands is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
CNSX:EURO Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Eurolife Brands Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:EURO Past Financials Data
Date (Data in CAD Millions) EPS *
2019-09-30 -0.03
2019-06-30 -0.04
2019-03-31 -0.03
2018-12-31 -0.03
2018-09-30 -0.03
2018-06-30 -0.02
2018-03-31 -0.02
2017-12-31 -0.02
2017-09-30 -0.01
2017-06-30 -0.01
2017-03-31 -0.01
2016-12-31 -0.01

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Eurolife Brands will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine Eurolife Brands's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. Eurolife Brands's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Healthcare companies here
  3. Eurolife Brands's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Eurolife Brands's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the North America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the North America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Eurolife Brands has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

EURO Past Performance

  How has Eurolife Brands performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Eurolife Brands's growth in the last year to its industry (Healthcare Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Eurolife Brands does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Eurolife Brands's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Eurolife Brands's 1-year growth to the North America Healthcare Services industry average as it is not currently profitable.
Earnings and Revenue History
Eurolife Brands's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Eurolife Brands Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:EURO Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-09-30 0.01 -6.53 6.38
2019-06-30 0.02 -6.34 6.32
2019-03-31 0.14 -5.99 6.13
2018-12-31 0.13 -4.74 4.93
2018-09-30 0.14 -3.61 3.71 -0.05
2018-06-30 0.12 -1.78 1.89 -0.04
2018-03-31 -0.88 0.88 -0.02
2017-12-31 -0.51 0.51
2017-09-30 0.00 -0.27 0.00 0.26
2017-06-30 0.00 -0.26 0.00 0.25
2017-03-31 0.00 -0.24 0.00 0.23
2016-12-31 0.14 -0.26 0.06 0.21
2015-12-31 0.01 -0.14 0.09

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Eurolife Brands has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Eurolife Brands has efficiently used its assets last year compared to the North America Healthcare Services industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Eurolife Brands improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Eurolife Brands's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Eurolife Brands has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

EURO Health

 How is Eurolife Brands's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Eurolife Brands's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Eurolife Brands is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Eurolife Brands has no long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Eurolife Brands's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Eurolife Brands has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Eurolife Brands Company Filings, last reported 4 months ago.

CNSX:EURO Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-09-30 5.51 0.00 0.63
2019-06-30 -0.01 0.14
2019-03-31 0.74 0.00 0.36
2018-12-31 0.41 0.00 0.22
2018-09-30 1.32 0.00 0.78
2018-06-30 1.36 0.00 1.20
2018-03-31 0.81 0.00 0.86
2017-12-31 1.18 0.00 1.23
2017-09-30 -0.40 0.00
2017-06-30 -0.39 0.00
2017-03-31 -0.37 0.00
2016-12-31 -0.35 0.00
2015-12-31 -0.09 0.00 0.01
  • Eurolife Brands has no debt.
  • Eurolife Brands currently has no debt however we can't compare to 5 years ago as we have no data for that period.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Eurolife Brands has less than a year of cash runway based on current free cash flow.
  • Eurolife Brands has less than a year of cash runway if free cash flow continues to grow at historical rates of 88.5% each year.
X
Financial health checks
We assess Eurolife Brands's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Eurolife Brands has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

EURO Dividends

 What is Eurolife Brands's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Eurolife Brands dividends.
If you bought CA$2,000 of Eurolife Brands shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Eurolife Brands's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Eurolife Brands's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
CNSX:EURO Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Global Healthcare Services Industry Average Dividend Yield Market Cap Weighted Average of 28 Stocks 0.7%
Canada Market Average Dividend Yield Market Cap Weighted Average of 336 Stocks 3.4%
Canada Minimum Threshold Dividend Yield 10th Percentile 1%
Canada Bottom 25% Dividend Yield 25th Percentile 1.9%
Canada Top 25% Dividend Yield 75th Percentile 5.3%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Eurolife Brands has not reported any payouts.
  • Unable to verify if Eurolife Brands's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Eurolife Brands's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Eurolife Brands has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Eurolife Brands's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Eurolife Brands afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Eurolife Brands has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

EURO Management

 What is the CEO of Eurolife Brands's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Shawn Moniz
COMPENSATION CA$998,750
TENURE AS CEO 2.4 years
CEO Bio

Mr. Shawn Moniz serves as the Chief Executive Officer and a Director of Eurolife Brands Inc. (Formerly known as Cannvas MedTech Inc.) since September 12, 2017 and June 09, 2017 respectively and also serves as its Chairman of the Board since December 31, 2018. As Chief Executive Officer, Mr. Moniz leads Eurolife Brands Inc. (Formerly known as Cannvas MedTech Inc.’s) strategic direction and overall firm-wide success. Mr. Moniz has vast experience in strategic CRM brand positioning and loyalty focus, marketing automation, digital data strategy and omni-channel data driven marketing. Being an exceptional strategic marketing technologist, he has a multitude of disciplinary backgrounds which have enabled him to take on significant roles in the leading the vision, innovation, growth strategy all while demonstrating excellent leadership and mentorship to junior team members. With his wealth of corporate leadership experience and technological expertise, Mr. Moniz enables Cannvas MedTech Inc. to establish a dominant presence in the growing cannabis economy. He recently served in the capacity of Senior Director of Strategic Solutions across three organizations including Klick Inc., where he delivered strategic CRM solutions to numerous Fortune 500 companies with clients such as Astellas, Takeda, Abbvie, Shire, Novartis, Novo Nordisk, UCB, NBA, Air Canada, John Hancock, Yum! Brands (Taco Bell, Pizza Hut, KFC), Pitney Bowes, Tim Hortons and Kraft US / Canada, Astra Zeneca and XM Sirius Radio.

CEO Compensation
  • Shawn's compensation has increased whilst company is loss making.
  • Shawn's remuneration is higher than average for companies of similar size in Canada.
Management Team

Shawn Moniz

TITLE
CEO & Chairman
COMPENSATION
CA$999K
TENURE
2.4 yrs

Miroslav Beganovic

TITLE
Chief Financial Officer
COMPENSATION
CA$86K
TENURE
1.9 yrs

Radu Puscasu

TITLE
Vice President of Technology
Board of Directors Tenure

Average tenure of the Eurolife Brands board of directors in years:

1
Average Tenure
  • The average tenure for the Eurolife Brands board of directors is less than 3 years, this suggests a new board.
Board of Directors

Shawn Moniz

TITLE
CEO & Chairman
COMPENSATION
CA$999K
TENURE
1.2 yrs

Derek Lloyd Ivany

TITLE
Chairman of the Advisory Board
TENURE
0.4 yrs

Marco Contardi

TITLE
Independent Director
TENURE
1.8 yrs

Lindsay Hamelin

TITLE
Independent Director
TENURE
1.8 yrs

Daniel Bal

TITLE
Member of the Medical Advisory Board
TENURE
1.6 yrs

Angela Smith

TITLE
Member of Cannabis Sciences Advisory Board
TENURE
1.1 yrs

Emma Chasen

TITLE
Member of Cannabis Sciences Advisory Board
TENURE
1 yrs

Dinesh Kandanchatha

TITLE
Member of Cannabis AI
AGE
43
TENURE
0.9 yrs

Aislin O'Hara

TITLE
Member of Medical Advisory Board
TENURE
0.9 yrs

Wesley Tulshi

TITLE
Member of Cannabis AI
TENURE
0.9 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by Eurolife Brands individual insiders in the past 3 months, but not in substantial volumes.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
15. Jan 19 Buy Lindsay Hamelin Individual 15. Jan 20 15. Jan 20 150,000 CA$0.05 CA$7,500
15. Jan 19 Buy Fusionworx Investment Group Inc. Company 15. Jan 20 15. Jan 20 2,000,000 CA$0.05 CA$100,000
28. Oct 19 Buy Fusionworx Investment Group Inc. Company 28. Oct 19 28. Oct 19 100,000 CA$0.10 CA$9,500
08. Oct 19 Buy Fusionworx Investment Group Inc. Company 27. Sep 19 27. Sep 19 2,500 CA$0.10 CA$238
16. Sep 19 Buy Fusionworx Investment Group Inc. Company 30. Aug 19 30. Aug 19 39,875 CA$0.11 CA$4,227
30. Aug 19 Buy Fusionworx Investment Group Inc. Company 27. Aug 19 29. Aug 19 414,000 CA$0.11 CA$42,644
22. Aug 19 Buy Fusionworx Investment Group Inc. Company 21. Aug 19 21. Aug 19 46,000 CA$0.10 CA$4,600
19. Aug 19 Buy Steve Loutskou Individual 16. Aug 19 16. Aug 19 32,900 CA$0.14 CA$4,441
16. Aug 19 Buy Fusionworx Investment Group Inc. Company 15. Aug 19 15. Aug 19 43,500 CA$0.13 CA$5,655
16. Aug 19 Buy FourOneSix Inc. Company 14. Aug 19 14. Aug 19 360,500 CA$0.14 CA$48,667
08. Aug 19 Buy Steve Loutskou Individual 07. Aug 19 07. Aug 19 5,800,000 CA$0.06 CA$333,498
08. Aug 19 Buy Shawn Moniz Individual 07. Aug 19 07. Aug 19 5,800,000 CA$0.06 CA$333,498
24. Jul 19 Buy Fusionworx Investment Group Inc. Company 15. Feb 19 03. Jul 19 2,848,000 CA$0.07 CA$159,452
17. Jul 19 Buy Lindsay Hamelin Individual 16. Jul 19 16. Jul 19 100,000 CA$0.05 CA$5,000
17. Jul 19 Buy Fusionworx Investment Group Inc. Company 16. Jul 19 16. Jul 19 500,000 CA$0.05 CA$25,000
17. Jul 19 Buy FourOneSix Inc. Company 16. Jul 19 16. Jul 19 500,000 CA$0.05 CA$25,000
06. Mar 19 Buy FourOneSix Inc. Company 05. Mar 19 05. Mar 19 22,000 CA$0.06 CA$1,292
X
Management checks
We assess Eurolife Brands's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Eurolife Brands has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

EURO News

Simply Wall St News

EURO Company Info

Description

Eurolife Brands Inc. operates as a business technology company within the health sciences sector in the United States and internationally. It operates Cannvas.Me, a platform that provides accessible and evidence-based education related to cannabis; and Cannvas Data platform that delivers deeper insights into industry trends, consumer behavior, and pre-purchasing patterns of cannabis consumption. The company was formerly known as Cannvas MedTech Inc. and changed its name to Eurolife Brands Inc. in August 2019. Eurolife Brands Inc. was incorporated in 2014 and is headquartered in Vancouver, Canada.

Details
Name: Eurolife Brands Inc.
EURO
Exchange: CNSX
Founded: 2014
CA$13,080,560
373,730,289
Website: http://www.eurolifebrands.com
Address: Eurolife Brands Inc.
750 West Pender Street,
Suite 804,
Vancouver,
British Columbia, V6C 2T7,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX EURO Common Shares Canadian National Stock Exchange CA CAD 03. Jul 2018
OTCPK EURP.F Common Shares Pink Sheets LLC US USD 03. Jul 2018
DB 3CMA Common Shares Deutsche Boerse AG DE EUR 03. Jul 2018
Number of employees
Current staff
Staff numbers
0
Eurolife Brands employees.
Industry
Health Care Technology
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/02/18 01:18
End of day share price update: 2020/02/14 00:00
Last earnings filing: 2019/11/29
Last earnings reported: 2019/09/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.